These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23273232)

  • 1. Clinical features and severity of psoriasis: a comparison of facial and nonfacial involvement in Iran.
    Keshavarz E; Roknsharifi S; Shirali Mohammadpour R; Roknsharifi M
    Arch Iran Med; 2013 Jan; 16(1):25-8. PubMed ID: 23273232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of facial psoriasis based on the distributions of facial lesions.
    Woo SM; Choi JW; Yoon HS; Jo SJ; Youn JI
    J Am Acad Dermatol; 2008 Jun; 58(6):959-63. PubMed ID: 18359126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between the Peripherofacial Psoriasis and Scalp Psoriasis.
    Kim KH; Ahn JY; Park MY; Youn JI
    Ann Dermatol; 2016 Aug; 28(4):422-6. PubMed ID: 27489422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is facial involvement a sign of severe psoriasis?
    Canpolat F; Cemil BC; Eskioğlu F; Akis HK
    Eur J Dermatol; 2008; 18(2):169-71. PubMed ID: 18424377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome: A cross-sectional study.
    Ranugha PSS; Bishnoi P; Chandrashekar L
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):522-527. PubMed ID: 31317874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
    Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience.
    Brazzelli V; Carugno A; Alborghetti A; Grasso V; Cananzi R; Fornara L; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1354-9. PubMed ID: 21973119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran.
    Jamshidi F; Bouzari N; Seirafi H; Farnaghi F; Firooz A
    Arch Iran Med; 2008 Mar; 11(2):162-5. PubMed ID: 18298293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe facial psoriasis with adalimumab.
    Noiles K; Vender R
    J Drugs Dermatol; 2008 Dec; 7(12):1165-7. PubMed ID: 19137771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and quality of life of patients with psoriasis in Chile.
    Valenzuela F; Silva P; Valdés MP; Papp K
    Actas Dermosifiliogr; 2011 Dec; 102(10):810-6. PubMed ID: 21664589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
    Jacobson CC; Kimball AB
    Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?
    Kwon HH; Kwon IH; Youn JI
    Int J Dermatol; 2012 Jan; 51(1):53-8. PubMed ID: 22182378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial involvement and the severity of psoriasis.
    Passos AN; de A Rêgo VRP; Duarte GV; Santos E Miranda RC; de O Rocha B; de F S P de Oliveira M
    Int J Dermatol; 2019 Nov; 58(11):1300-1304. PubMed ID: 31347152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).
    Lambert J; Dowlatshahi EA; de la Brassinne M; Nijsten T
    Eur J Dermatol; 2012; 22(2):231-7. PubMed ID: 22266338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
    Berth-Jones J; Thompson J; Papp K;
    Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial involvement in Iranian psoriatic patients and its relation to severity of the disease.
    Rassai S; Feily A; Sina N; Hajikaramian A
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1488-9. PubMed ID: 20384685
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
    Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
    J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.